mutations specified The point that, as defined down below, CLL therapy relies around the presence or absence of such mutations. The existing consensus is usually that, other than clonal mutations, subclonal mutations having a variant allelic frequency ranging from 5 to ten% (and thus under the edge of detection by common molecular tactics) could al